Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs587780586
rs587780586
0.010 GeneticVariation BEFREE •Systematic comparison of R850Q with three other SCN8A epilepsy mutations, T761I, R1617Q, R1872Q, identifies one common dysfunction in resurgent current, although these mutations alter distinct properties of the channel. 31715021

2020

dbSNP: rs786205866
rs786205866
0.010 GeneticVariation BEFREE We described a new case, a boy with severe intellectual disability with absent speech, autistic spectrum disorder, mild dysmorphic facial features, failure to thrive and epilepsy associated to a de novo heterozygous missense mutation in EEF1A2 (c.364G>A; p.Glu122Lys) identified by next generation sequencing; it was already reported in other studies. 31477274

2020

dbSNP: rs1047891
rs1047891
0.010 GeneticVariation BEFREE In conclusion, the SNP rs1047891 was associated with VPA-induce HA among epilepsy patients. 31151073

2019

dbSNP: rs10818488
rs10818488
0.010 GeneticVariation BEFREE The rs3761847 SNP was associated with epilepsy under a dominant model, whereas rs10818488 was associated with CSF cellularity and parasite load under dominant and recessive models, respectively. 31570557

2019

dbSNP: rs121918363
rs121918363
0.010 GeneticVariation BEFREE Subsequent experimental studies demonstrated that SRPX2 is needed for vocalization and synapse formation in mice, and that both silencing SRPX2 and injecting (p.Asn327Ser) in mouse models results in alteration in neuronal migration in cerebral cortex and epilepsy. 30393191

2019

dbSNP: rs121918782
rs121918782
0.010 GeneticVariation BEFREE Both p.Thr956Met and p.Tyr790Phe were previously described in unrelated patients with epilepsies within the GEFS+ spectrum. 30977726

2019

dbSNP: rs1373040226
rs1373040226
0.010 GeneticVariation BEFREE A novel compound heterozygous mutation of the STAMBP (c.1119‑1G>T, c.968A>G) was identified in the present study and epilepsy was refractory, consistent with previously reported cases. 31638258

2019

dbSNP: rs1373411103
rs1373411103
0.010 GeneticVariation BEFREE A novel compound heterozygous mutation of the STAMBP (c.1119‑1G>T, c.968A>G) was identified in the present study and epilepsy was refractory, consistent with previously reported cases. 31638258

2019

dbSNP: rs17611
rs17611
C5
0.010 GeneticVariation BEFREE This work aimed to study the possible relevance for human neurocysticercosis of single nucleotide polymorphisms (SNPs) in the C5-<i>TRAF1</i> region (rs17611 <i>C/T</i>, rs992670 <i>G/A</i>, rs25681 <i>G/A</i>, rs10818488 <i>A/G</i>, and rs3761847 <i>G/A</i>) in a Mexican population and associated with clinical and radiological traits related to neurocysticercosis severity (cell count in the cerebrospinal fluid [CSF cellularity], parasite location and parasite load in the brain, parasite degenerating stage, and epilepsy). 31570557

2019

dbSNP: rs199681253
rs199681253
0.010 GeneticVariation BEFREE However, the introduction of R800W in parallel with the epilepsy-linked mutation D434G (D434G/R800W) decreased the amplitude of AP-evoked BK currents compared with D434G alone. 31849601

2019

dbSNP: rs200345816
rs200345816
0.010 GeneticVariation BEFREE The second individual had a homozygous missense mutation (c.1929C>A [p.His643Gln]) and presented with developmental delay and epilepsy in childhood. 30982608

2019

dbSNP: rs2235076
rs2235076
0.010 GeneticVariation BEFREE We did not detect significant association between rs9390754 and rs2235076 within GRIK2 gene and epilepsy risk. 30908586

2019

dbSNP: rs2274924
rs2274924
0.010 GeneticVariation BEFREE The TRPM6 rs2274924 polymorphism may be associated with susceptibility to epilepsy following stroke, and the C allele may be associated with increased risk of post-stroke epilepsy. 30739590

2019

dbSNP: rs2304016
rs2304016
0.010 GeneticVariation BEFREE This study identified no significant associations of allelic or genotypic SNPs with the susceptibility of epilepsy and medication response with an exception of rs2304016 and rs2499697 SNPs that were associated with the generalized type of epilepsy among Jordanian population. 31297029

2019

dbSNP: rs2499697
rs2499697
0.010 GeneticVariation BEFREE This study identified no significant associations of allelic or genotypic SNPs with the susceptibility of epilepsy and medication response with an exception of rs2304016 and rs2499697 SNPs that were associated with the generalized type of epilepsy among Jordanian population. 31297029

2019

dbSNP: rs25681
rs25681
C5
0.010 GeneticVariation BEFREE This work aimed to study the possible relevance for human neurocysticercosis of single nucleotide polymorphisms (SNPs) in the C5-<i>TRAF1</i> region (rs17611 <i>C/T</i>, rs992670 <i>G/A</i>, rs25681 <i>G/A</i>, rs10818488 <i>A/G</i>, and rs3761847 <i>G/A</i>) in a Mexican population and associated with clinical and radiological traits related to neurocysticercosis severity (cell count in the cerebrospinal fluid [CSF cellularity], parasite location and parasite load in the brain, parasite degenerating stage, and epilepsy). 31570557

2019

dbSNP: rs3213607
rs3213607
0.010 GeneticVariation BEFREE Both rs4840200-T and rs3213607-A, and the interactions between rs4840200 and rs9390754 are related to the increased risk of epilepsy risk. 30908586

2019

dbSNP: rs368001837
rs368001837
0.010 GeneticVariation BEFREE Patient 1 (NM_153033.4: c.[533C > T], NP_694578: p.[(Ala178Val)]) was a 17-year-old girl who presented with early-onset epilepsy resembling epilepsia partialis continua (responsive to intravenous corticosteroids and immunoglobulins), and later developed myoclonic seizures and atypical absences, photosensitivity to very low frequencies and progressive seizures-related neurocognitive and motor deterioration. 30500434

2019

dbSNP: rs3761847
rs3761847
0.010 GeneticVariation BEFREE The rs3761847 SNP was associated with epilepsy under a dominant model, whereas rs10818488 was associated with CSF cellularity and parasite load under dominant and recessive models, respectively. 31570557

2019

dbSNP: rs42938
rs42938
0.010 GeneticVariation BEFREE The objective of this study was to determine whether three common genetic polymorphisms [apolipoprotein (APOE) ε4 (rs42938 and rs7412), brain derived neurotrophic factor (BDNF) Met (rs6265), and catechol-O-methyltransferase (COMT) Val (rs4680)] are associated with increased psychiatric symptomatology in individuals with pharmacoresistant epilepsy. 30909076

2019

dbSNP: rs4840200
rs4840200
0.010 GeneticVariation BEFREE Both rs4840200-T and rs3213607-A, and the interactions between rs4840200 and rs9390754 are related to the increased risk of epilepsy risk. 30908586

2019

dbSNP: rs572427454
rs572427454
0.010 GeneticVariation BEFREE To validate our findings further, we obtained an in-depth comparison of two novel mutations [GABRB3 (N328D) and GABRB3 (E357K)] associated with epilepsy with different severities of epilepsy phenotype. 31435640

2019

dbSNP: rs587777365
rs587777365
0.010 GeneticVariation BEFREE One patient carried previously reported p.P83S variant with autism spectrum disorder (ASD) phenotype that has not yet been described related to GABRG2 disorders and a more severe epilepsy phenotype than reported earlier. 31004928

2019

dbSNP: rs7412
rs7412
0.010 GeneticVariation BEFREE The objective of this study was to determine whether three common genetic polymorphisms [apolipoprotein (APOE) ε4 (rs42938 and rs7412), brain derived neurotrophic factor (BDNF) Met (rs6265), and catechol-O-methyltransferase (COMT) Val (rs4680)] are associated with increased psychiatric symptomatology in individuals with pharmacoresistant epilepsy. 30909076

2019

dbSNP: rs763000109
rs763000109
TNF
0.010 GeneticVariation BEFREE Our findings suggest that the MnSOD Ala16Val SNP might have an important role in epilepsy, mainly in patients with generalized seizures and particularly with VV genotype. 31212050

2019